Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
EBITDA Growth
4.02%
Quarterly · Period ending:
CANF EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported4.02%period ending
Latest reported4.02%period ending
CANF Quarterly EBITDA YoY % (-19.11% → 4.02%)
Year-over-year change
High-resolution chart · PNG
CANF ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 4.0205% | |
| 4.0205% | |
| -25.335% | |
| -25.335% | |
| -19.1058% | |
| -19.1058% | |
| -10.0942% | |
| -8.246% | |
| -14.9719% | |
| 24.4416% | |
| 40.5667% | |
| 27.554% | |
| 13.8849% | |
| -14.4517% | |
| 23.4812% | |
| 26.7322% | |
| 33.9405% | |
| -9.1559% | |
| -15.2822% | |
| -41.6683% | |
| 18.2602% | |
| 49.2569% | |
| -92.2886% | |
| 10.3242% | |
| -33.7059% | |
| -151.5455% | |
| 47.0082% | |
| -2,958.7258% | |
| -177.0198% | |
| -7.7003% | |
| 23.9403% | |
| 84.4094% | |
| 43.3002% | |
| 7.4005% | |
| -111.8074% | |
| 71.5587% | |
| -11.1776% | |
| -48.5994% | |
| -321.3004% | |
| 1.44% | |
| -6.0809% | |
| -207.1755% | |
| 72.4794% | |
| -93.5597% | |
| 2.5812% | |
| 79.0196% | |
| 46.709% | |
| 26.0416% | |
| 7.4591% | |
| -3.4639% | |
| -78.6216% | |
| -20.5906% | |
| -43.6193% | |
| -11.6881% | |
| -64.5683% | |
| -15.0854% | |
| -0.1244% | |
| -11.8143% | |
| -24.5069% | |
| -19.1086% |